Fairtree Asset Management’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.86M Buy
25,944
+352
+1% +$33.1K 0.71% 45
2026
Q1
$3.03M Sell
25,592
-3,673
-13% -$454K 1.39% 16
2025
Q4
$3.68M Buy
29,265
+13,194
+82% +$1.72M 1.69% 15
2025
Q3
$2.35M Buy
16,071
+11,509
+252% +$1.74M 1.54% 15
2025
Q2
$711K Buy
+4,562
New +$723K 0.54% 59
2025
Q1
Sell
-2,238
Closed -$365K 114
2024
Q4
$365K Buy
+2,238
New +$400K 0.35% 84

Other funds holding ZTS

Fairtree Asset Management's ZTS Position: Q2 2026 in Review

Fairtree Asset Management increased its Zoetis (ZTS) stake by 1.4% in Q2 2026, buying an estimated $33.1K and bringing the position to 25,944 shares worth $1.86M. The position accounts for 0.71% of the portfolio, ranked #45.

Fairtree Asset Management first reported a position in ZTS in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.68M in Q4 2025. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Fairtree Asset Management held 25,944 shares of Zoetis worth $1.86M as of Q2 2026.
  • Fairtree Asset Management bought 352 Zoetis shares in Q2 2026, an estimated $33.1K.
  • Zoetis made up 0.71% of Fairtree Asset Management's portfolio in Q2 2026, its #45 holding.
  • Fairtree Asset Management first reported a position in Zoetis in Q4 2024 and has held it in 6 quarters since.
  • Fairtree Asset Management's Zoetis position peaked at $3.68M in Q4 2025.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Fairtree Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.